These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 9636188)

  • 1. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.
    Kaplan DH; Shankaran V; Dighe AS; Stockert E; Aguet M; Old LJ; Schreiber RD
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7556-61. PubMed ID: 9636188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of IFN-gamma in tumor transplantation immunity and inhibition of chemical carcinogenesis.
    Blankenstein T; Qin Z
    Curr Opin Immunol; 2003 Apr; 15(2):148-54. PubMed ID: 12633663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.
    Dighe AS; Richards E; Old LJ; Schreiber RD
    Immunity; 1994 Sep; 1(6):447-56. PubMed ID: 7895156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical function for type I interferons in cancer immunoediting.
    Dunn GP; Bruce AT; Sheehan KC; Shankaran V; Uppaluri R; Bui JD; Diamond MS; Koebel CM; Arthur C; White JM; Schreiber RD
    Nat Immunol; 2005 Jul; 6(7):722-9. PubMed ID: 15951814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-gamma is the inducer of indoleamine 2,3-dioxygenase in allografted tumor cells undergoing rejection.
    Takikawa O; Habara-Ohkubo A; Yoshida R
    J Immunol; 1990 Aug; 145(4):1246-50. PubMed ID: 2116480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular immune privilege is circumvented by CD4+ T cells, leading to the rejection of intraocular tumors in an IFN-{gamma}-dependent manner.
    Dace DS; Chen PW; Alizadeh H; Niederkorn JY
    J Leukoc Biol; 2007 Feb; 81(2):421-9. PubMed ID: 17077163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of PTEN causes SHP2 activation, making lung cancer cells unresponsive to IFN-γ.
    Chen CL; Chiang TH; Tseng PC; Wang YC; Lin CF
    Biochem Biophys Res Commun; 2015 Oct; 466(3):578-84. PubMed ID: 26385178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of IFN gamma in protection against tumor development and cancer immunoediting.
    Ikeda H; Old LJ; Schreiber RD
    Cytokine Growth Factor Rev; 2002 Apr; 13(2):95-109. PubMed ID: 11900986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reaction.
    Qin Z; Kim HJ; Hemme J; Blankenstein T
    J Exp Med; 2002 Jun; 195(11):1479-90. PubMed ID: 12045246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation of endogenously produced interferon gamma in interleukin 4-mediated tumor rejection.
    Nishihori H; Tsuji H; Wang H; Tahara H; Akiyama M; Ogawa Y; Matsushima K; Iwakura Y; Mukaida N
    Hum Gene Ther; 2000 Mar; 11(5):659-68. PubMed ID: 10757346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma delta T cells provide an early source of interferon gamma in tumor immunity.
    Gao Y; Yang W; Pan M; Scully E; Girardi M; Augenlicht LH; Craft J; Yin Z
    J Exp Med; 2003 Aug; 198(3):433-42. PubMed ID: 12900519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of IFN-gamma in rejection of established tumors by IL-12 : source of production and target.
    Segal JG; Lee NC; Tsung YL; Norton JA; Tsung K
    Cancer Res; 2002 Aug; 62(16):4696-703. PubMed ID: 12183428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas.
    Böhm W; Thoma S; Leithäuser F; Möller P; Schirmbeck R; Reimann J
    J Immunol; 1998 Jul; 161(2):897-908. PubMed ID: 9670968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rat mammary adenocarcinoma 13762 expressing IFN-gamma elicits antitumor CD4+ MHC class II-restricted T cells that are cytolytic in vitro and tumoricidal in vivo.
    Frey AB
    J Immunol; 1995 May; 154(9):4613-22. PubMed ID: 7722313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells.
    Ferrantini M; Giovarelli M; Modesti A; Musiani P; Modica A; Venditti M; Peretti E; Lollini PL; Nanni P; Forni G
    J Immunol; 1994 Nov; 153(10):4604-15. PubMed ID: 7963533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
    Hafner M; Falk W; Echtenacher B; Männel DN
    Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15.
    Gri G; Chiodoni C; Gallo E; Stoppacciaro A; Liew FY; Colombo MP
    Cancer Res; 2002 Aug; 62(15):4390-7. PubMed ID: 12154045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma and cancer immunoediting.
    Dunn GP; Ikeda H; Bruce AT; Koebel C; Uppaluri R; Bui J; Chan R; Diamond M; White JM; Sheehan KC; Schreiber RD
    Immunol Res; 2005; 32(1-3):231-45. PubMed ID: 16106075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-γ-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling.
    Gao Y; Yang J; Cai Y; Fu S; Zhang N; Fu X; Li L
    Int J Cancer; 2018 Aug; 143(4):931-943. PubMed ID: 29516506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.